1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Drug News 20 OCTOBER 2014

Cancer Drug News 20 OCTOBER 2014

  • October 2014
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Fully Personalised Cancer Vaccines On The Rise
Industry Trend Analysis - Pfizer's Palbociclib On Route For 2015 Launch
Industry Brief - Galena Receives Japanese Patent Allowance Covering NeuVax
Industry Brief - Pharmacyclics/Roche Enter Deal To Evaluate Imbruvica/Gazyva In Lymphoma And Leukaemia
Industry Trend Analysis - Imbruvica Has A Fighting Chance In CLL Market
Industry Trend Analysis - J&J Bolsters Immunotherapy Pipeline With Second Aduro Collaboration
Industry Trend Analysis - Nanobiotix' NBTXR3 To Make The Unresectable Resectable
Industry Brief - Eisai's Lenvatinib Gains FDA Priority Review Designation For RAI-Refractory DTC
Industry Brief - Nanobiotix Earns Second Milestone Payment From Bpifrance For NBTXR3 Development
Industry Brief - Immutep Receives Australian NoA For Patent Covering IMP321
Industry Brief - Heidelberg/Roche Extend Collaboration To Develop ATACs
Industry Brief - COT Adds Canadian Patent To COTI-2 Intellectual Property Portfolio
Industry Trend Analysis - Roche Bets On NewLink With USD1bn Deal
Industry Brief - OctreoPharm's OPS202 Gains FDA ODD For NETs
Industry Brief - Rigontec Raises Funds To Advance RNA-Based Immunotherapeutics For Cancer/Viral Diseases
Industry Brief - DNAtrix Raises Funds To Advance DNX-2401 In Glioblastoma
Industry Brief - Daiichi Sankyo Submits Tender Offer For Shares In Ambit Biosciences
Industry Brief - Bicycle Raises Funds For Development Of BDCs In Oncology
Industry Trend Analysis - Roche's Oncology Portfolio Reinforcement Securing Growth

Table Of Contents

Cancer Drug News 20 OCTOBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident ...

Drugs and Diagnostics for Hematological Disorders: Global Markets

Drugs and Diagnostics for Hematological Disorders: Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Receive detailed information regarding screening, testing and treatment options for hematological disorders and blood cancer. - Learn about the types of diagnostic and treatment ...

Hematological Malignancies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Hematological Malignancies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • November 2016
  • by Transparency Market Research

Hematological Malignancies Market: Overview This report provides in-depth region wise and country wise analysis of the hematological malignancies market. Stakeholders of this report include manufacturers ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market

  • January 2017
    19 pages
  • Therapy  

    Anticoagulant  

    Cancer  

View report >

Cancer Statistics in Denmark

  • January 2017
    6 pages
  • Therapy  

  • Denmark  

View report >

Hormone and Therapy Market in Pakistan and the US

  • January 2017
    7 pages
  • Hormone  

    Therapy  

    Diabetes  

  • Pakistan  

    United States  

View report >

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.